家族性高胆固醇血症(Familial hypercholesterolemia,FH)主要是由于低密度脂蛋白受体(Low-density lipoprotein receptor,LDLR)基因突变导致的单基因显性遗传性疾病。FH患者LDLR基因突变导致细胞膜表面LDLR减少或缺如,机体代谢胆固醇能力降低,血浆胆固醇增高并沉积在不同的组织和器官,常伴有全身黄色瘤和早发冠心病,因此FH也是最常见的严重代谢性疾病。世界范围内对LDLR基因突变的报道总共有1741种,经整理我国目前报道的140例FH指示病例,包括108种LDLR基因突变类型。文章对已报道的中国FH患者LDLR基因突变特点进行系统分析和综述,旨在为FH诊断治疗提供参考依据。
Familial hypercholesterolemia(FH),one monogenic autosomal dominant disease,mainly results from genetic defects in the low-density lipoprotein receptor(LDLR) gene,which leads to the reduction or absence of cell surface LDLR,disorder of cholesterol metabolism,and cholesterol deposition in different tissues and organs.FH is a common metabolic disease clinically characterized by the presence of xanthomas and premature coronary heart disease.To date,about 1 741 variants have been identified in gene LDLR,among which 108 variants were identified in Chinese FH patients.To better understand the features of LDLR gene mutations and help to FH diagnosis and therapy,this review provides a comprehensive overview of LDLR gene mutations in Chinese FH patients.